SalihiSPerçinBErkengelHI, et al.Does COVID-19 infection increase the risk of pulmonary embolism in ambulatory patients with deep vein thrombosis. Vascular2021: ■■■: 17085381211052207.
2.
BikdeliBMadhavanMVJimenezD, et al.COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol2020; 75: 2950–2973.
3.
KlokFAKruipMJHAvan der MeerNJM, et al.Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res2020; 191: 145–147.
4.
van DamLFKroftLJMvan der WalLI, et al.Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: a different phenotype of thrombotic disease?Thromb Res2020; 193: 86–89.
5.
SuhYJHongHOhanaM, et al.Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis. Radiology2021; 298(2): E70–E80.
6.
JiménezDGarcía-SanchezARaliP, et al.Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest2021; 159(3): 1182–1196.
7.
Giorgi-PierfranceschiMPaolettiOPanA, et al.Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study. Intern Emerg Med2020; 15(8): 1425–1433.
